Unraveling the Role of Autotaxin and Lysophosphatidic Acid in Alzheimer's Disease: From Molecular Mechanisms to Therapeutic Potential. [PDF]
García-de Soto J +14 more
europepmc +1 more source
Design of a phase II randomised, double-blind, placebo-controlled, dose-finding trial of BI 1819479 in patients with idiopathic pulmonary fibrosis. [PDF]
Wuyts WA +9 more
europepmc +1 more source
Bone Marrow Mononuclear Cells Administration Restore Lysophosphatidic Acid (LPA) Levels and Cellular Signaling Axis in Rats Submitted to Renal Ischemia-Reperfusion. [PDF]
Mattos-Silva P +3 more
europepmc +1 more source
Recent Developments and Applications of Capillary and Microchip Electrophoresis in Proteomics and Peptidomics (2023-2025). [PDF]
Štěpánová S, Kašička V.
europepmc +1 more source
Identify GDPD3 as a key regulator of epithelial-mesenchymal transition and prostate adenocarcinoma progression via the LPA/LPAR1/AKT axis: transcriptomic and experimental study. [PDF]
Hao L +11 more
europepmc +1 more source
Oxypeucedanin attenuates neuropathic pain in male mice via inhibiting lysophosphatidic acid receptor signaling. [PDF]
Li J +11 more
europepmc +1 more source
Liraglutide attenuates aluminum chloride-induced Alzheimer's disease in rats by modulating the oxLDL/LPA/LPAR1 pathway. [PDF]
Abo El-Magd NF, Ramadan NM, Eraky SM.
europepmc +1 more source
Metabolic reprogramming of efferocytosis in the tumour microenvironment: From apoptotic-cell clearance to therapeutic targeting. [PDF]
Yang Q, Yan J, Yang Q.
europepmc +1 more source
Emerging complexities of phospholipid metabolism in adipose tissue. [PDF]
Kim M +5 more
europepmc +1 more source
Pharmacological Blockade of LPAR1 Does Not Provide Neuroprotection in a Rat Model of Ocular Hypertensive Glaucoma. [PDF]
Kocherlakota S +6 more
europepmc +1 more source

